The Tobacco Product Evaluation and Expose Core (Core B) will provide members of AHA Tobacco Regulation and Addiction Center (A-TRAC) the research capabilities to identify and evaluate tobacco product composition and constituents;to perform realistic tobacco product exposures in animal models such that delivery of tobacco products that replicates real world human exposures;to measure biomarkers of tobacco exposure;and to develop analytical techniques and approaches that improve our understanding of the complex relationship between markers of tobacco exposure and biomarkers of cardiovascular injury (see Core C). The Core will serve both the needs of Center projects and be an active research Core in its own right as it develops new and improved techniques that enhance the breadth and sensitivity of detection of tobacco product constituents and promotes better understanding of new and emerging tobacco products.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
1P50HL120163-01
Application #
8595396
Study Section
Special Emphasis Panel (ZRG1-BDCN-Q (40))
Project Start
2013-09-19
Project End
Budget Start
2013-09-19
Budget End
2014-08-31
Support Year
1
Fiscal Year
2013
Total Cost
$748,465
Indirect Cost
Name
American Heart Association
Department
Type
DUNS #
073284507
City
Dallas
State
TX
Country
United States
Zip Code
75231
Bahelah, Raed; Ward, Kenneth D; Ben Taleb, Ziyad et al. (2018) Determinants of progression of nicotine dependence symptoms in adolescent waterpipe smokers. Tob Control :
Weaver, Scott R; Kim, Hyoshin; Glasser, Allison M et al. (2018) Establishing consensus on survey measures for electronic nicotine and non-nicotine delivery system use: Current challenges and considerations for researchers. Addict Behav 79:203-212
Mwasongwe, Stanford; Min, Yuan-I; Booth 3rd, John N et al. (2018) Masked hypertension and kidney function decline: the Jackson Heart Study. J Hypertens 36:1524-1532
Keith, Rachel J; Fetterman, Jessica L; Riggs, Daniel W et al. (2018) Protocol to assess the impact of tobacco-induced volatile organic compounds on cardiovascular risk in a cross- sectional cohort: Cardiovascular Injury due to Tobacco Use study. BMJ Open 8:e019850
Mwasongwe, Stanford E; Young, Bessie; Bidulescu, Aurelian et al. (2018) Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study. BMC Nephrol 19:239
Gibson, Laura A; Creamer, MeLisa R; Breland, Alison B et al. (2018) Measuring perceptions related to e-cigarettes: Important principles and next steps to enhance study validity. Addict Behav 79:219-225
Riggs, Daniel W; Yeager, Ray A; Bhatnagar, Aruni (2018) Defining the Human Envirome: An Omics Approach for Assessing the Environmental Risk of Cardiovascular Disease. Circ Res 122:1259-1275
Fetterman, Jessica L; Weisbrod, Robert M; Feng, Bihua et al. (2018) Flavorings in Tobacco Products Induce Endothelial Cell Dysfunction. Arterioscler Thromb Vasc Biol 38:1607-1615
Ma, Jennie Z; Hart, Joy L; Walker, Kandi L et al. (2018) Perceived health risks of electronic nicotine delivery systems (ENDS) users: The role of cigarette smoking status. Addict Behav :
Wan, Ma; Bennett, Brian D; Pittman, Gary S et al. (2018) Identification of Smoking-Associated Differentially Methylated Regions Using Reduced Representation Bisulfite Sequencing and Cell type-Specific Enhancer Activation and Gene Expression. Environ Health Perspect 126:047015

Showing the most recent 10 out of 82 publications